257 related articles for article (PubMed ID: 16888202)
21. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
22. Central pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) decrease the baroreflex sensitivity in trout.
Lancien F; Mimassi N; Conlon JM; Le Mével JC
Gen Comp Endocrinol; 2011 Apr; 171(2):245-51. PubMed ID: 21320504
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Brenneman DE
Peptides; 2007 Sep; 28(9):1720-6. PubMed ID: 17513014
[TBL] [Abstract][Full Text] [Related]
24. Role of VIP and PACAP in islet function.
Winzell MS; Ahrén B
Peptides; 2007 Sep; 28(9):1805-13. PubMed ID: 17559974
[TBL] [Abstract][Full Text] [Related]
25. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
Dejda A; Jozwiak-Bebenista M; Nowak JZ
Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
[TBL] [Abstract][Full Text] [Related]
26. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) activate protein kinase C in chick cerebral cortex.
Nowak JZ; Dejda A; Zawilska JB
Pol J Pharmacol; 2001; 53(6):695-9. PubMed ID: 11985349
[TBL] [Abstract][Full Text] [Related]
27. PACAP (pituitary adenylate cyclase-activating peptide)-like immunoreactivity in the gill arch of the goldfish, Carassius auratus: distribution and comparison with VIP.
de Girolamo P; Arcamone N; Rosica A; Gargiulo G
Cell Tissue Res; 1998 Sep; 293(3):567-71. PubMed ID: 9716747
[TBL] [Abstract][Full Text] [Related]
28. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
[TBL] [Abstract][Full Text] [Related]
29. Identification of key residues that cause differential gallbladder response to PACAP and VIP in the guinea pig.
Wei M; Fujiki K; Ando E; Zhang S; Ozaki T; Ishiguro H; Kondo T; Nokihara K; Wray V; Naruse S
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G76-83. PubMed ID: 16901992
[TBL] [Abstract][Full Text] [Related]
30. PACAP and VIP promote initiation of electrophysiological activity in differentiating embryonic stem cells.
Chafai M; Louiset E; Basille M; Cazillis M; Vaudry D; Rostène W; Gressens P; Vaudry H; Gonzalez BJ
Ann N Y Acad Sci; 2006 Jul; 1070():185-9. PubMed ID: 16888163
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide inhibit feeding in the chick brain by different mechanisms.
Tachibana T; Tomonaga S; Oikawa D; Saito S; Takagi T; Saito ES; Boswell T; Furuse M
Neurosci Lett; 2003 Sep; 348(1):25-8. PubMed ID: 12893417
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of VIP-induced neuroprotection against neonatal excitotoxicity.
Rangon CM; Dicou E; Goursaud S; Mounien L; Jégou S; Janet T; Muller JM; Lelièvre V; Gressens P
Ann N Y Acad Sci; 2006 Jul; 1070():512-7. PubMed ID: 16888217
[TBL] [Abstract][Full Text] [Related]
33. PACAP and VIP prevent apoptosis in schwannoma cells.
Castorina A; Tiralongo A; Giunta S; Carnazza ML; Rasi G; D'Agata V
Brain Res; 2008 Nov; 1241():29-35. PubMed ID: 18835258
[TBL] [Abstract][Full Text] [Related]
34. VIP and PACAP stimulate TSH release from the bullfrog pituitary.
Okada R; Yamamoto K; Ito Y; Mochida H; Tonon MC; Fournier A; Leprince J; Vaudry H; Kikuyama S
Peptides; 2007 Sep; 28(9):1784-9. PubMed ID: 17482721
[TBL] [Abstract][Full Text] [Related]
35. The effects of PACAP and VIP on the in vitro melatonin secretion from the embryonic chicken pineal gland.
Faluhelyi N; Reglodi D; Csernus V
Ann N Y Acad Sci; 2006 Jul; 1070():271-5. PubMed ID: 16888177
[TBL] [Abstract][Full Text] [Related]
36. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.
Ganea D; Rodriguez R; Delgado M
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):127-42. PubMed ID: 12887096
[TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic protein down-regulation of neuronal pituitary adenylate cyclase-activating polypeptide and reciprocal effects on vasoactive intestinal peptide expression.
Pavelock KA; Girard BM; Schutz KC; Braas KM; May V
J Neurochem; 2007 Feb; 100(3):603-16. PubMed ID: 17181550
[TBL] [Abstract][Full Text] [Related]
38. Stimulatory effect of n-octanoylated ghrelin on locomotor activity in the goldfish, Carassius auratus.
Matsuda K; Miura T; Kaiya H; Maruyama K; Uchiyama M; Kangawa K; Shioda S
Peptides; 2006 Jun; 27(6):1335-40. PubMed ID: 16297501
[TBL] [Abstract][Full Text] [Related]
39. Opposing effects by pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission.
Ciranna L; Cavallaro S
Exp Neurol; 2003 Dec; 184(2):778-84. PubMed ID: 14769370
[TBL] [Abstract][Full Text] [Related]
40. Cyclic AMP formation in C6 glioma cells: effect of PACAP and VIP in early and late passages.
Sokolowska P; Nowak JZ
Ann N Y Acad Sci; 2006 Jul; 1070():566-9. PubMed ID: 16888226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
